Cargando…
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab
Patient: Male, 57-year-old Final Diagnosis: Febrile neutropenia Symptoms: Fever Medication: Nivolumab Clinical Procedure: Chemotherapy Specialty: Oncology OBJECTIVE: Adverse events of drug therapy BACKGROUND: Nivolumab is a human IgG4 monoclonal antibody against human programmed cell death 1 (PD-1)....
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020738/ https://www.ncbi.nlm.nih.gov/pubmed/32018275 http://dx.doi.org/10.12659/AJCR.920809 |